Vision Source Eyecare is enrolling patients to participate in a clinical trial that evaluates the effect of a redness relief eye drop when used simultaneously with a glaucoma eye drop.
Patients being treated with the FDA-approved intraocular pressure lowering eye drop often experience eye redness. This study involves evaluating the redness side effect and how it subsides with use of another FDA-approved over-the-counter drop designed to relieve the redness.
Enrollment is now open! If you or someone you know is currently being treated for primary open angle glaucoma or ocular hypertension, reach out to our Research Team for more information. Patients who meet the inclusion criteria will be eligible for compensation.

18-75 years old
4 visits over 2 months
Held at the Plaza, Kansas City North, and Maryville locations
Up to $320 in compensation
Exams and eye drops will be provided at no cost while participating in the study